Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.
This trial is randomized an blind to the physician who is analyzing the results.It has been select adults; both sex; ASA I and II. These patients must be submitted to hip arthroplasty replacement. The anesthesia technique is single shot spinal anesthesia. Primary endpoint: assessment alternative; technique replacement volemic with HES 130/04. Secondary endpoint: haemostatic abnormalities; blood loss; transfusion blood.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
48
Dosage: 30ml/kg; frequency: one time; duration: 60min
Dosage: 30ml/kg; frequency: one time; duration: 60min.After 10ml-kg-h both groups
Institute of Orthopedics and Traumatology of HCFMUSP
São Paulo, São Paulo, Brazil
HES expansion plasmatic efficacy
Time frame: 24 hours
Blood transfusion
Time frame: 24 hours
Haemostatic alterations
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.